Avita Medical | 1811094D - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Accuray USD 124.78M 2.54M 2025-12
Celltrion KRW 411.27B 998.23M 2026-03
Clinuvel Pharmaceuticals AUD 17.25K 80.1K 2025-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Mayne Pharma AUD 2.66M 153K 2025-06
Medical Developments International AUD 1.5M 167K 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Edge NZD 126K 425K 2026-06
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
Pharma Mar EUR 32.13M 1.04M 2026-06
Polynovo AUD 15.39M 663K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Qiagen NV USD 1.63B 19.45M 2026-06
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 404.17M 248K 2026-03
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Telix Pharmaceuticals AUD 564.44M 115.99M 2026-06
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 172.8M 9.49M 2026-06